ARCHIVES

Hagop Kantarjian: Why Drugs Cost Too Much and How Prices Can be Brought Down

This article is from The Cancer Letter archive.

Vol. 39 No. 22 | May 31, 2013

Download PDF Visit The Full Archive

Related Articles

In Brief: Pediatric Groups Endorse Merger Plan; NCI Charters Consumer Liaison Group

November 13, 1998

Protocols Approved During the Month of June 2002

July 26, 2002

In Brief: Reducing Doses Cuts Cure Rate Every Time, DeVita Says; Hyperthermia Use In Cancer Being Assessed

April 6, 1984

Civin Moves From Hopkins To Maryland To Direct Stem Cell Medicine Center

January 9, 2009

Caris Officials Respond To Questions Submitted By The Cancer Letter

August 8, 2014

In Brief: White House Appoints Six to NCAB; Calabrisi To Succeed Korn As Chairman; 2 Spaces Vacant

January 25, 1991